Appeal No. 2001-1779 Application No. 09/398,898 determined. Such secondary considerations as commercial success, long felt but unsolved needs, failure of others, etc., might be utilized to give light to the circumstances surrounding the origin of the subject matter sought to be patented. As indicia of obviousness or nonobviousness, these inquiries may have relevancy. (Citation omitted.) “[T]o establish obviousness based on a combination of the elements disclosed in the prior art, there must be some motivation, suggestion or teaching of the desirability of making the specific combination that was made by the applicant.” In re Kotzab, 217 F.3d 1365, 1370, 55 USPQ2d 1313, 1316 (Fed. Cir. 2000), citing In re Dance, 160 F.3d 1339, 1343, 48 USPQ2d 1635, 1637 (Fed. Cir. 1998) and In re Gordon, 733 F.2d 900, 902, 221 USPQ 1125, 1127 (Fed. Cir. 1984). One cannot establish motivation for combining references through unsupported conclusory statements. In re Lee, 277 F.3d 1338, 1343, 61 USPQ2d 1430, 1434 (Fed. Cir. 2002). From the outset, the examiner’s rationale for holding claim 2 obvious over the cited references is unclear. The examiner states initially that “WO ‘069 and US ‘926 teach all of the limitations of the claim.” Examiner’s Answer, page 4. In view of this statement, it is unclear what the examiner considers to be the differences between the claim and the prior art, and how the prior art should be modified so as to meet the limitations present in the claim, as required by John Deere, supra. While the examiner asserts that “[i]t is within the skill of the art to determine the amount of active agent needed to achieve a beneficial and/or therapeutic effect” (Examiner’s Answer, page 4), the examiner does not provide 8Page: Previous 1 2 3 4 5 6 7 8 9 10 11 NextLast modified: November 3, 2007